FIRST MANHATTAN CO. LLC. - UROGEN PHARMA LTD ownership

UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 85 filers reported holding UROGEN PHARMA LTD in Q3 2019. The put-call ratio across all filers is 1.12 and the average weighting 0.3%.

Quarter-by-quarter ownership
FIRST MANHATTAN CO. LLC. ownership history of UROGEN PHARMA LTD
ValueSharesWeighting
Q3 2023$14,010
+35.4%
1,0000.0%0.00%
Q2 2023$10,350
+12.0%
1,0000.0%0.00%
Q1 2023$9,240
+4.2%
1,0000.0%0.00%
Q4 2022$8,870
+10.9%
1,0000.0%0.00%
Q3 2022$8,0000.0%1,0000.0%0.00%
Q2 2022$8,0000.0%1,0000.0%0.00%
Q1 2022$8,000
-11.1%
1,0000.0%0.00%
Q4 2021$9,000
-43.8%
1,0000.0%0.00%
Q3 2021$16,000
+6.7%
1,0000.0%0.00%
Q2 2021$15,000
-21.1%
1,0000.0%0.00%
Q1 2021$19,000
+5.6%
1,0000.0%0.00%
Q4 2020$18,000
-5.3%
1,0000.0%0.00%
Q3 2020$19,000
-26.9%
1,0000.0%0.00%
Q2 2020$26,000
+52.9%
1,0000.0%0.00%
Q1 2020$17,000
+6.2%
1,000
+100.0%
0.00%
Q4 2019$16,000
+45.5%
5000.0%0.00%
Q3 2019$11,000
-35.3%
5000.0%0.00%
Q2 2019$17,0005000.00%
Other shareholders
UROGEN PHARMA LTD shareholders Q3 2019
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 2,620,545$36,713,8356.69%
Wildcat Capital Management, LLC 495,606$6,943,4402.79%
SILVERARC CAPITAL MANAGEMENT, LLC 508,883$7,129,4512.16%
Opaleye Management Inc. 320,000$4,483,2001.46%
AlphaCentric Advisors LLC 165,000$2,311,6501.31%
Soleus Capital Management, L.P. 372,000$5,211,7200.48%
EAM Investors, LLC 170,523$2,389,0270.46%
RA Capital Management 1,483,697$20,786,5950.41%
Parkman Healthcare Partners LLC 145,311$2,035,8070.37%
MENORA MIVTACHIM HOLDINGS LTD. 2,303,031$32,265,4640.29%
View complete list of UROGEN PHARMA LTD shareholders